Mineralys Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	635	354	-	-	-
Enterprise Value	412	117	-110	-11	3
PE Ratio	-4.92	-4.92	-	-	-
PB Ratio	2.69	1.47	-	-	-
P/FCF Ratio	-4.35	-4.35	-	-	-
P/OCF Ratio	-4.35	-4.35	-	-	-
EV/EBITDA Ratio	-1.63	-1.63	3.70	0.55	-0.93
EV/EBIT Ratio	-1.63	-1.63	3.70	0.55	-0.93
EV/FCF Ratio	-1.44	-1.44	3.77	0.73	-1.25
Debt / Equity Ratio	-	-	-	-	-1.25
Debt / EBITDA Ratio	-	-	-	-	-1.36
Debt / FCF Ratio	-	-	-	-	-1.83
Quick Ratio	22.57	22.57	13.65	2.10	0.28
Current Ratio	23.77	23.77	13.98	2.20	0.29
Interest Coverage	-	-	-	-	-28.79
Return on Equity (ROE)	-26.50%	-26.50%	79.30%	146.40%	-
Return on Assets (ROA)	-25.50%	-25.50%	-47.50%	-307.80%	-
Return on Capital (ROIC)	-35.10%	-35.10%	60.22%	81.68%	-325.91%
Earnings Yield	-11.09%	-20.34%	-	-	-
FCF Yield	-12.52%	-22.96%	-	-	-
Buyback Yield / Dilution	-600.33%	-600.33%	-3.67%	90.03%	-
Total Shareholder Return	-600.33%	-600.33%	-3.67%	90.03%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).